The drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market.
Furthermore, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.

The market is segmented based on route of administration, facility of use, and region. Based on route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market. This can be attributed to the factors such as, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe. No special training is required for the administration of these drugs, which is a major factor driving the growth of this market.

Based on facility of use, the drug delivery technology market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool. Additionally, the increasing need for drug administration due to the rising prevalence of chronic diseases, patient compliance, and safety are all factors contributing to the growth of the market for hospitals.

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While, North America is expected to dominate the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021） MAM-MD-5119 / MarketsandMarkets / 2017年3月27日 / 当調査レポートでは、局所ドラッグデリバリ（局所薬物送達）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品種類別分析、需要先別分析、地域別分析、局所ドラッグデリバリ（局所薬物送達）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. The market is segmented based on product type, route of administration, facility of use, and regions. On the basis of product type, the market is segmented into formulations and devices (transdermal drug delivery). Transdermal drug delivery is expected to offer lucrative growth opportunities and represents a new revenue...

経鼻ドラッグデリバリー技術の世界市場予測（～2021年）：点鼻薬、スプレー、粉、ジェル MAM-MD4892 / MarketsandMarkets / 2017年1月11日 / MarketsandMarketsが発行した当調査レポートでは、経鼻ドラッグデリバリー技術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、投与形態別分析、システム別分析、治療分野別分析、需要先別分析、経鼻ドラッグデリバリー技術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the market. Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for player operating in the market. On the other hand, complications...

睡眠時無呼吸症治療装置の世界市場予測（～2021）：製品別、治療別（CPAP、APAP、BPAP、マスク、口腔装置（下顎前方固定装置）、診断別、需要先別 MAM-MD-1181 / MarketsandMarkets / 2017年1月4日 / 当調査レポートでは、睡眠時無呼吸症治療装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、治療別分析、診断別分析、需要先別分析、睡眠時無呼吸症治療装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The sleep apnea devices market is projected to reach USD 6.70 Billion by 2021 from USD 4.59 Billion in 2016, growing at a CAGR of 7.8% during the forecast period. Factors such as growing awareness regarding the ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are driving the growth of the market. The global market is segmented on the basis of product and end user. On the basis of product, the market is categorized into therapeutic devices and diagnostic devices. In 2016, the...

免疫療法治療薬の世界市場予測（～2021）：薬種類別（成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ）、治療分野別、需要先別、地域別 MAM-PH-3926 / MarketsandMarkets / 2017年1月6日 / 当調査レポートでは、免疫療法治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、薬種類別分析、治療分野別分析、需要先別分析、地域別分析、免疫療法治療薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunotherapy drugs market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, the high cost of immunotherapy treatment, and high attrition rate in the product development cycle are the major factors hindering the growth of the market. However, rising opportunities in the emerging markets, and immunotherapy as...

肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場予測（～2021年） MAM-MD-5021 / MarketsandMarkets / 2017年2月20日 / 当調査レポートでは、肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、デバイス別分析、需要先別分析、地域別分析、肺疾患・呼吸器疾患ドラックデリバリー（薬物送達）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis is expected to drive the market growth during the forecast period. However, emerging markets and growth in online marketing channel offers opportunities for the market. The pulmonary drug delivery market is segmented based on formulations, canister type,...

コート紙の世界市場予測（～2021）：コーティング材別（GCC、PCC、シーサタイト、スチレン・ブタジエン系ラテックス、デンプン、タルク、ワックス）、種類別、用途別 MAM-CH-4939 / MarketsandMarkets / 2017年1月23日 / 当調査レポートでは、コート紙の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、取付別分析、モデル別分析、形態別分析、構成要素別分析、コート紙の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The industrial agitators market was valued at USD 2.56 Billion in 2016 and is expected to reach USD 3.86 Billion by 2022, at a CAGR of 7.07% during the forecast period. The growth of this market is being propelled by the increasing demand for industrial agitators, especially from the chemical and pharmaceutical industries. The report covers the industrial agitators market on the basis of mounting, model, form, component, industry, and geography. The industrial agitators market is expected to be led by pharmaceutical industry during the forecast period. The growth of this market is being propelled by the high demand for...